ARTICLE;
COST MINIMIZATION ANALYSIS;
DRUG COST;
HEALTH CARE COST;
HEALTH CARE POLICY;
HEALTH INSURANCE;
HOME CARE;
HUMAN;
PHOTOTHERAPY;
PSORIASIS;
AMBULATORY CARE;
COMPARATIVE STUDY;
COST;
COST CONTROL;
ECONOMICS;
INSTRUMENTATION;
INSURANCE;
PATIENT ATTITUDE;
PSORIATIC ARTHRITIS;
PUVA;
STATISTICS;
UNITED STATES;
ANTI-INFLAMMATORY AGENTS;
ARTHRITIS, PSORIATIC;
COST SAVINGS;
DEDUCTIBLES AND COINSURANCE;
HEALTH CARE COSTS;
HOME NURSING;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOLOGIC FACTORS;
IMMUNOSUPPRESSIVE AGENTS;
INSURANCE CARRIERS;
INSURANCE COVERAGE;
MANAGED CARE PROGRAMS;
OFFICE VISITS;
PATIENT ACCEPTANCE OF HEALTH CARE;
PSORIASIS;
PUVA THERAPY;
RECEPTORS, TUMOR NECROSIS FACTOR;
ULTRAVIOLET THERAPY;
UNITED STATES;
Feldman S.R., Koo J.Y., Lebwohl M.G., Menter A., Van Voorhees A. The Psoriasis and Psoriatic Arthritis Pocket Guide: Treatment Algorithms and Management Options. 2005. National Psoriasis Foundation. Ref Type: Pamphlet
Strategy to manage the treatment of severe psoriasis: Considerations of efficacy, safety and cost
Feldman SR, Garton R, Averett W, Balkrishnan R, Vallee J. Strategy to manage the treatment of severe psoriasis: considerations of efficacy, safety and cost. Expert Opin Pharmacother 2003;4(9):1525-33.
Yelverton CB, Kulkarni AS, Balkrishnan R, Feldman SR. Home ultraviolet B phototherapy: a cost-effective option for severe psoriasis. Manag Care Interface 2006;19(1):33-6, 39.
Yelverton CB, Kulkarni AS, Balkrishnan R, Feldman SR. Home ultraviolet B phototherapy: a cost-effective option for severe psoriasis. Manag Care Interface 2006;19(1):33-6, 39.
5
84868953280
Accessed
National Psoriasis Foundation. Online Major Health Plans' Insurance Policies. http://www.psoriasis.org/medical/practice/insurers/links.php. Accessed: 8-17- 2007.
Blue Cross of California. Clinical UM Guideline: Biologics for Psoriasis and Psoriatic Arthritis. http://medpolicy.bluecrossca.com/policies/ guidelines/DRUG/psoriasis-arthritis.html. Accessed: 7-27-2007.
Blue Cross of California. Clinical UM Guideline: Biologics for Psoriasis and Psoriatic Arthritis. http://medpolicy.bluecrossca.com/policies/ guidelines/DRUG/psoriasis-arthritis.html. Accessed: 7-27-2007.
9
66249139301
Blue Cross of California. Medical Policy: Ultraviolet Light, Including Laser Therapy, for the Treatment of Skin Disorders (MED.00008). http://medpolicy.bluecrossca.com/policies/ MED/UV-skin-disorders.html. Accessed: 7-27-2007.
Blue Cross of California. Medical Policy: Ultraviolet Light, Including Laser Therapy, for the Treatment of Skin Disorders (MED.00008). http://medpolicy.bluecrossca.com/policies/ MED/UV-skin-disorders.html. Accessed: 7-27-2007.
10
66249104399
CIGNA. Healthcare Coverage Position: Phototherapy and Photochemotherapy for Dermatological Conditions. http://www.cigna.com/customer-care/healthcare- professional/ coverage-positions/medical/ mm-0031-coveragepositioncriteria- phototherapy-and-photochemotherapy.pdf. Accessed: 7-27-2007.
CIGNA. Healthcare Coverage Position: Phototherapy and Photochemotherapy for Dermatological Conditions. http://www.cigna.com/customer-care/healthcare- professional/ coverage-positions/medical/ mm-0031-coveragepositioncriteria- phototherapy-and-photochemotherapy.pdf. Accessed: 7-27-2007.
Effect of continued ultraviolet B phototherapy on the duration of remission of psoriasis: A randomized study
PubMed
Stern RS, Armstrong RB, Anderson TF, Bickers DR, Lowe NJ, Harber L et al. Effect of continued ultraviolet B phototherapy on the duration of remission of psoriasis: a randomized study. J Am Acad Dermatol 1986;15(3):546-52. [PubMed]
